Jim Fink

Currently Chief Science Officer for Aerogen Pharma Corporation, San Mateo, CA. Dr. Fink serves as Adjunct Professor for the Respiratory Therapy Program at Rush Medical School in Chicago, IL, and Visiting Professor, Department of Physical therapy, Universidade Federal de Pernambuco, Recife, Brazil. Jim has a PhD in Pharmaceutical Innovation from Bradford University, UK. A respiratory therapist by training and practice, Jim was Technical Director of Respiratory Care at Medical Center UCSF for 14 years. Dr. Fink was Fellow of Respiratory Science at Nektar Therapeutics and Aerogen Ltd. developing novel aerosol delivery systems for critically ill adults and infants with more than 40 issued patents, and 200 + peer reviewed papers. He is a fellow of the International Society of Aerosols in Medicine, the American Association for Respiratory Care, and the American College of Chest Physicians. Jim was awarded the Forest M. Bird Lifetime Scientific Achievement award from the American Respiratory Care Foundation. Jim is currently involved in development of systems for administration of aerosol surfactant to treat preterm infants in Low and Middle Income Countries.